Before taking this medicine

The document does not explicitly outline clinical precautions for Oriahnn use.

Clinical Precautions for Oriahnn Administration

The document does not provide explicit information regarding clinical precautions, contraindications, or monitoring requirements for Oriahnn. 

It focuses on regulatory and packaging aspects, referencing compliance with FDA reporting requirements under 21 CFR 314.80 and 314.81. As such, specific clinical precautions, such as patient selection criteria, risk factors, or necessary laboratory monitoring, are not specified in the description.